0001493152-23-020797.txt : 20230609 0001493152-23-020797.hdr.sgml : 20230609 20230609180021 ACCESSION NUMBER: 0001493152-23-020797 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EAGLE CRAIG CENTRAL INDEX KEY: 0001562135 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 231006601 MAIL ADDRESS: STREET 1: POST OFFICE BOX 4590 CITY: NEW YORK STATE: NY ZIP: 10163 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0407 4 2023-06-07 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001562135 EAGLE CRAIG 855 N. WOLFE STREET, SUITE 601 BALTIMORE MD 21205 1 0 0 0 0 Employee Stock Option (Right to Buy) 1.66 2023-06-07 4 A 0 475000 0 A 2028-06-07 Common Stock 475000 475000 D The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date. /s/ Craig Eagle 2023-06-09